O

Oppenheimer & Co. Inc.

Global wealth management and investment bank

Branch Operations Specialist

Full-Time
No salary listed
Mid
St. Louis, MO, USA
In Person
Finance & Banking

About the job

Requirements
  • FINRA Series 99 registration is required within six months of hire.
  • Brokerage operations experience is required.
  • Strong attention to detail and accuracy are required.
  • Intermediate Microsoft Office skills are required.
  • Ability to navigate multiple computer systems and applications and use search tools to find information is required.
  • Verbal, written, and interpersonal communication skills are required.
  • Organizational, multitasking, and prioritizing skills are required.
  • Ability to work independently and as a member of a team is required.
Responsibilities
  • Assist in maintaining day-to-day operations to ensure operational excellence.
  • Support the client onboarding process.
  • Maintain and process documents.
  • Assist with audit preparations.
  • Communicate with home office personnel.
  • Interact with and support branch staff and all levels of management.
  • Interact on routine and sensitive matters.
  • Ensure that all documents are sent to the home office in a timely manner.
  • Cross-train within other positions in the Operations area.
  • Take on additional tasks as needed.

About the company

O

Oppenheimer & Co. Inc.

View

Oppenheimer & Co. Inc. is a global financial services firm serving clients since 1881, offering wealth management, capital markets, and investment banking. Services include financial planning, equities and fixed income trading and research, and M&A and capital-raising advisory for institutions and mid-market companies. What sets Oppenheimer apart is pairing over a century of experience with tailored, research-driven strategies for individuals and institutions alike. The goal is to help clients grow and protect wealth across market conditions.

Company Size

N/A

Company Stage

IPO

Headquarters

New York City, New York

Founded

1881

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue rose 21.9% to $454.9 million, driven by advisory fees.
  • Public finance momentum accelerated; 2026 competitive underwriting rank improved to No. 18.
  • Hiring seven derivatives specialists and Eric Nortman expanded financing capabilities across institutional clients.

What critics are saying

  • Advisor attrition persists; DFX counted 60 departures and net negative recruiting over 12 months.
  • FINRA disputes remain live; the Brookman expungement battle involved Oppenheimer in 2026.
  • Oppenheimer depends on volatile capital markets; one dry deal cycle quickly compresses revenue and bonuses.

What makes Oppenheimer & Co. Inc. unique

  • Independent broker-dealer with wealth management, investment banking, and 88 U.S. branches.
  • Municipal finance franchise strengthened by Beth Coolidge’s MSRB board seat and hires.
  • Selective advisor platform attracts niche talent, including athlete-focused recruiting and $7.2 billion Next-Gen network.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus

Company News

Yahoo Finance
Oct 25th, 2026
Oppenheimer: web and commerce software outlook improves, AI fears linger; Shopify target raised to $205

Interest in web and e-commerce software stocks has improved ahead of third-quarter results, but worries that artificial intelligence could hurt the businesses persist, Oppenheimer said in a note. It expects Shopify's revenue growth to beat Wall Street's 31.6% forecast by 2 to 3 percentage points, helped by strong consumer demand. Oppenheimer raised its price target on the company to $205 from $175. Wix.com is expected to meet forecasts of 10% bookings growth and 12% revenue growth. Weaker demand from smaller designers and partners, as activity shifts to AI tools such as Base44, could delay faster growth. GoDaddy is expected to report bookings growth of 5.0%, in line with forecasts. Commerce.com is expected to report revenue in line with an $83.5 million forecast.

Oppenheimer & Co. Inc.
Oct 1st, 2026
Insights from Oppenheimer's radiopharmaceutical summit.

Insights from Oppenheimer's radiopharmaceutical summit. Oppenheimer & Co. Inc. October 01, 2026 This year, Oppenheimer's 4th Annual Targeted Radiopharmaceutical Therapies Summit, sponsored by Mintz and RSM, convened more than 200 senior biotechnology executives, institutional investors, and key stakeholders from across the radiopharmaceutical therapy ecosystem at Lotte New York Palace in New York City. Hosted and moderated by Oppenheimer Managing Director and Senior Analyst, Jeff Jones, PhD, the summit featured in-depth discussions with industry leaders from over a dozen companies, including AstraZeneca, Novartis, RayzeBio/Bristol Myers Squibb, Aktis Oncology, Perspective Therapeutics, and AdvanCell. Conversations focused on the scientific, clinical, logistical, and commercial factors shaping the next phase of growth in radiopharmaceutical therapies, including product optimization, asset quality, target and isotope selection, and clinical development strategy. The breadth and depth of dialogue reflected the sector's continued maturation, with an estimated 30 clinical-stage companies and ~90 candidates in clinical development, while the only two marketed products today generated ~$3B in 2025 revenue. Companies are increasingly concentrating on differentiated assets, broadening the scope of the opportunity, refining product profiles, and maximizing long-term value creation. This year's inclusion of pharmaceutical industry leaders further underscored the growing strategic importance of radiopharmaceutical therapies within the broader biopharmaceutical landscape. Panelists offered valuable perspectives on partnership activity, business development priorities, and the increasingly important role of radiopharmaceuticals in long-term portfolio strategies. As interest in the sector continues to accelerate, the summit served as an important forum for exchanging ideas, sharing perspectives, and exploring the developments shaping the future of radiopharmaceutical therapies. Oppenheimer remains committed to convening industry leaders and delivering differentiated insights on emerging areas of innovation across healthcare and life sciences. Oppenheimer Holdings, Inc. thank its speakers, panelists, attendees, and partners for contributing to another successful summit and look forward to continuing the conversation as the radiopharmaceutical therapy landscape evolves.

Yahoo Finance
Sep 30th, 2026
Oppenheimer tips FuelCell Energy and Innoviva for 66% gains on AI power and healthcare growth

Oppenheimer has identified two stocks with significant upside potential: FuelCell Energy and Innoviva. The investment bank sees gains of up to 66% over the next 12 months. FuelCell Energy, which develops modular fuel-cell systems for commercial and industrial customers, received an Outperform rating with a $24 price target, implying 42% upside from $16.90. Analyst Colin Rusch believes the company's technology positions it to benefit from growing data-centre electricity demand. FuelCell announced an agreement with Fit Energy in June involving up to 380 megawatts of capacity. Innoviva, which combines respiratory drug royalties with critical-care and infectious-disease treatments, was given a $35 price target, suggesting 66% upside from $21.11. Analyst Les Sulewski notes the company's specialty therapeutics business delivered 26% year-over-year growth in US product sales to $36.6 million during the second quarter.

Yahoo Finance
Sep 30th, 2026
Oppenheimer names top software stocks as AI spending shifts from adoption to ROI focus

Oppenheimer analysts say AI in software has moved beyond experimentation, with companies now required to demonstrate measurable returns on investment. AI is becoming a recurring operating expense, with chief financial officers evaluating investments alongside labour costs. The firm says system-of-record vendors and businesses with seat-plus-consumption pricing models are best positioned to benefit. These models offer protection against disruption and the clearest path to AI-driven growth. Oppenheimer's top picks include Microsoft Corporation, citing accelerating platform demand and over $1 billion in AI-related revenue. ServiceNow is highlighted for its exposure to automation and security tailwinds, also exceeding $1 billion in AI revenue. Braze is noted as a system-of-record for customer engagement with durable competitive advantages.

GlobeNewswire
Sep 22nd, 2026
Peapack Private appoints Kevin Bertscha as Senior Vice President, Chief Audit Executive.

Peapack Private appoints Kevin Bertscha as Senior Vice President, Chief Audit Executive. BEDMINSTER, N.J., Sept. 22, 2026 (GLOBE NEWSWIRE) - Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) and Peapack Private Bank & Trust are pleased to announce the appointment of Kevin Bertscha, CPA, as Senior Vice President, Chief Audit Executive. In this role, Bertscha will lead the Bank's internal audit function, overseeing audit strategy, risk assessment, regulatory compliance, internal controls, and governance processes supporting the Company's commitment to strong governance, effective risk management, regulatory compliance, and sustainable growth. Bertscha brings more than 30 years of financial services and internal audit experience, with a distinguished track record of overseeing audit programs for complex financial institutions, broker-dealers, and critical government securities clearing operations. Throughout his career, he has demonstrated expertise in risk management, regulatory compliance, operational resilience, corporate governance, and the implementation of best practices designed to strengthen organizational effectiveness and transparency. Prior to joining Peapack Private, Bertscha served as Managing Director and Deputy Audit Director at Oppenheimer & Co., where he partnered with executive leadership to modernize the firm's annual risk assessment process, enhance audit reporting frameworks, and oversee the execution of high-risk regulatory audits covering broker-dealer operations and financial risk management. Previously, he served as Managing Director and Chief Audit Executive at Industrial and Commercial Bank of China Financial Services, where he was responsible for all internal audit activities, including enterprise risk assessments, audit planning and execution, issue validation, and reporting to senior management, regulatory agencies, and governance committees. He also played a key role in coordinating audit and regulatory activities following a significant cybersecurity incident. Earlier in his career, Bertscha spent more than 25 years with BNY Mellon where he held several senior leadership positions including, Managing Director and Senior Audit Director for the Internal Audit Department, Chief Audit Executive for Global Securities Services, and Global Head of Audit for Pershing, Clearance and Collateral Management, and Treasury Services. He began his financial services career at Bankers Trust Company in New York, serving in both the Global Internal Audit Department and Corporate Trust & Agency division. Bertscha earned a Bachelor of Science degree in Accounting from Rutgers University School of Business. He is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants, The New Jersey Society of Certified Public Accountants, and The Institute of Internal Auditors. He also holds FINRA Series 7, 24, and 63 licenses. Additionally, he serves as an Executive Committee Member of the Prosight Internal Audit Council and holds the Certified Fiduciary and Investment Risk Specialist (CFIRS) designation. He is currently pursuing the Certified Information Systems Auditor (CISA) certification. About the Company Peapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $8.0 billion and assets under management and/or administration of $13.9 billion as of June 30, 2026. Founded in 1921, Peapack Private Bank & Trust is a commercial bank that offers a client-centric approach to banking, providing high-quality products along with customized and innovative wealth management, investment banking, commercial and personal banking solutions. The Bank's wealth management division offers comprehensive financial, tax, fiduciary and investment advice and solutions to individuals, families, privately held businesses, family offices, and not-for-profit organizations, which help them establish, maintain, and expand their legacy. Peapack Private Bank & Trust offers an unparalleled commitment to client service. Visit www.peapackprivate.com for more information.